Phathom Pharmaceuticals Inc share price logo

Phathom Pharmaceuticals Inc Share Price

NASDAQ: PHAT

Small Cap

$10.99

-0.49

(-4.27%)

as on

Phathom Pharmaceuticals Inc Stock Performance

as on September 17, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $10.84
    $11.63
    downward going graph

    1.36%

    Downside

    5.82%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.21
    $19.71
    downward going graph

    79.89%

    Downside

    79.34%

    Upside

    downward going graph

Phathom Pharmaceuticals Inc share price movements today

Previous Close
$11.48
Open
$11.55
Volume
943.3K
Day's Low - High
$10.84 - $11.63
52 Week Low - High
$2.21 - $19.71

Phathom Pharmaceuticals Inc Historical Returns

1 Month Return
+ 12.11 %
3 Month Return
+ 7.89 %
1 Year Return
-39.23 %
3 Year Return
+ 10.6 %
5 Year Return
-68.83 %

Phathom Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Phathom Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$840.0M

EPS (TTM)

-2.6725

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-268.3M

Revenue (TTM)

114.0M

Profit Margin

-289.51%

Return On Equity TTM

1762600.00%

Phathom Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Phathom Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$840.0M-68.83%NA-289.51%
BUY$61.1B251.26%-505.15-12.96%
NA$38.7BNANA-3.89%
BUY$101.2B47.46%28.0931.86%
BUY$59.6B0.6%14.131.37%

Stock Returns calculator for Phathom Pharmaceuticals Inc Stock including INR - Dollar returns

The Phathom Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Phathom Pharmaceuticals Inc investment value today

Current value as on today

₹63,046

Returns

₹36,954

(-36.95%)

Returns from Phathom Pharmaceuticals Inc Stock

₹41,821 (-41.82%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Phathom Pharmaceuticals Inc Stock

Based on 14 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 14 analysts, 85.71% of analysts recommend a 'BUY' rating for Phathom Pharmaceuticals Inc. Average target price of $21.38

Phathom Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Phathom Pharmaceuticals Inc.

What analysts predicted

48.6%UPSIDE

Target Price

$21.38

Current Price

$10.99

Analyzed by

14 Analysts

Target

$21.38

Phathom Pharmaceuticals Inc target price $21.38, a slight upside of 48.6% compared to current price of $10.99. According to 14 analysts rating.

Phathom Pharmaceuticals Inc Stock's Interest Amongst Investors

Search interest for Phathom Pharmaceuticals Inc Stock has decreased by -63% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-63% versus previous 30 day period

Phathom Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
0
1
7
16
29
28
39
Gross Profit
0
0
0
0
1
5
13
25
24
34
Operating Income
-30
-31
-35
-69
-69
-77
-70
-59
-78
-59
EBITDA
-28
-31
-33
-66
-65
-73
-66
-55
-78
-58
Interest Expense
9
9
10
13
17
17
18
18
18
17
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-37
-40
-43
-79
-82
-91
-85
-74
-94
-75
Income Tax Expense
0
9
7
-16
0
-
-
-
-
-
Net Income
-37
-40
-43
-79
-82
-91
-85
-74
-94
-75
Net Profit Margin
0.00%
0.00%
0.00%
-11667.16%
-4333.26%
-1248.58%
-523.34%
-250.98%
-330.71%
-191.91%

Phathom Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
-
0
55
Gross Profit
-
0
0
0
0
0
47
Operating Income
-1
-106
-125
-135
-172
-167
-277
EBITDA
0
-250
-124
-134
-171
-159
-261
Interest Expense
0
4
4
6
27
41
72
Depreciation
-
0
0
0
0
0
0
Income Before Tax
-1
-255
-129
-143
-197
-201
-334
Income Tax Expense
0
-45
4
4
25
41
-
Net Income
-1
-209
-133
-148
-223
-201
-334
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
-29558.94%
-605.09%

Phathom Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-40
-43
-79
-82
-91
-85
-74
-94
-75
Operating Cash Flow
-22
-31
-43
-69
-70
-63
-63
-84
-62
Investing Cash Flow
0
0
-
0
0
0
0
0
0
Financing Cash Flow
141
0
211
9
24
122
26
-
0
Change in Cash
119
-32
167
-59
-45
58
-37
-84
-62

Phathom Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-255
-129
-143
-197
-201
-334
Operating Cash Flow
-36
-69
-148
-146
-137
-266
Investing Cash Flow
-25
-1
0
-1
-1
0
Financing Cash Flow
304
114
44
120
367
182
Change in Cash
242
43
-104
-27
228
-84

Global Institutional Holdings in Phathom Pharmaceuticals Inc

Funds
Holdings
Medicxi Ventures Management (Jersey) Ltd
10.65%
Amvescap Plc.
5.21%
The Carlyle Group Inc
4.99%
BlackRock Inc
4.74%
Vanguard Group Inc
3.96%

Insights on Phathom Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Beone Medicines Ltd has given 68.2% return, outperforming this stock by 106.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 100.9%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, PHAT stock has moved down by -6.8%

About Phathom Pharmaceuticals Inc

phathom pharmaceuticals, inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. the company has the rights in the united states, europe, and canada to vonoprazan, a potassium-competitive acid blocker (p-cab) that blocks acid secretion in the stomach. it is also developing vonoprazan, which is in phase iii clinical trials for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of helicobacter pylori infection. the company was incorporated in 2018 and is based in buffalo grove, illinois.
OrganisationPhathom Pharmaceuticals Inc
Headquarters100 Campus Drive, Florham Park, NJ, United States, 07932
IndustryHealth Technology
CEOMr. Steven L. Basta M.B.A.
E-voting on sharesClick here to vote

Key Management of Phathom Pharmaceuticals Inc

Name

Title

Ms. Susan Kim

Senior Vice President of Marketing

Dr. Eckhard Leifke M.D., Ph.D.

Chief Medical Officer

Mr. David A. Socks

Co-Founder

Ms. Anne Marie Cook Esq., J.D.

Chief Legal Officer & Corporate Secretary

Mr. Robert Breedlove

VP of Finance & Principal Accounting Officer

Mr. Jonathan Bentley

Senior VP and Head of Sales, Operations & Training

Mr. Bill Aprea J.D.

Senior VP, Chief Compliance Officer & Deputy Chief Legal Officer

Mr. Paul Cocja

Chief People Officer

Dr. Azmi Nabulsi M.D., M.P.H.

Co-Founder

Mr. Steven L. Basta M.B.A.

CEO, President & Director

FAQs

What is Phathom Pharmaceuticals Inc share price today?

Phathom Pharmaceuticals Inc share price today is $10.99 as on at the close of the market. Phathom Pharmaceuticals Inc share today touched a day high of $11.63 and a low of $10.84.

What is the 52 week high and 52 week low for Phathom Pharmaceuticals Inc share?

Phathom Pharmaceuticals Inc share touched a 52 week high of $19.71 on and a 52 week low of $2.21 on . Phathom Pharmaceuticals Inc stock price today i.e. is closed at $10.99,which is 44.24% down from its 52 week high and 397.29% up from its 52 week low.

What is Phathom Pharmaceuticals Inc's market capitalisation today?

Phathom Pharmaceuticals Inc market capitalisation is $0.00T as on .

How to invest in Phathom Pharmaceuticals Inc Stock (PHAT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Phathom Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Phathom Pharmaceuticals Inc Shares that will get you 0.1365 shares as per Phathom Pharmaceuticals Inc share price of $10.99 per share as on September 17, 2025 at 1:29 am IST.

What is the minimum amount required to buy Phathom Pharmaceuticals Inc Stock (PHAT) from India?

Indian investors can start investing in Phathom Pharmaceuticals Inc (PHAT) shares with as little as ₹88.042 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Phathom Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Phathom Pharmaceuticals Inc share’s latest price of $10.99 as on September 17, 2025 at 1:29 am IST, you will get 0.9099 shares of Phathom Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that Phathom Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Phathom Pharmaceuticals Inc stock has given -68.83% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?